Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators
Results from the Triggers of Ventricular Arrhythmias (TOVA) study
William Whang, MD, MS*,*,
Christine M. Albert, MD, MPH*, ,
Samuel F. Sears, Jr, PhD ,
Rachel Lampert, MD ,
Jamie B. Conti, MD ,
Paul J. Wang, MD||,
Jagmeet P. Singh, MD, DPhil*,
Jeremy N. Ruskin, MD*,
James E. Muller, MD*,
Murray A. Mittleman, MD, DrPH¶ TOVA Study Investigators
* Cardiovascular Division, Massachusetts General Hospital, Boston, Massachusetts
Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts
University of Florida Health Science Center, Gainesville, Florida
Yale-New Haven Medical Center, New Haven, Connecticut
|| Stanford University Medical Center, Stanford, California
¶ Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts

View larger version (13K):
[in a new window]
|
Figure 1 Time to first appropriate implantable cardioverter-defibrillator (ICD) discharge by presence of depression according to Centers for Epidemiologic Studies-Depression scale score 16 (p = 0.02, log-rank test).
|
|
|